← Retour 🔗 Vue partagée — Acme Corporation · Lecture seule

HORIZON-JU-EDCTP3-2026-Outstanding Research Team Prize

European Commission · Horizon Europe · EU
1.7
Score global

Résumé

This is a Horizon Europe recognition prize call for outstanding research teams under the EDCTP3 (European & Developing Countries Clinical Trials Partnership) joint undertaking, with an application deadline of 2 September 2026. The call operates within the 2021-2027 Horizon Europe programme period. No attachment documents are available to provide additional details on eligibility criteria, budget, or specific requirements.

Analyse d'adéquation

This is a recognition prize for outstanding research teams under the EDCTP3 (European & Developing Countries Clinical Trials Partnership) program, focused on clinical research in infectious diseases and global health. Acme Corporation, a semiconductor and AI company, is ineligible as the call explicitly targets research institutions and universities conducting clinical trials, which falls entirely outside the client's domain.

Scores détaillés

Pertinence 1.0/10
Urgence 8.0/10
Adéquation stratégique 1.0/10

Brief exécutif

Low

Pas d'analyse approfondie — ce score ≤ 6,0 n'a pas déclenché l'analyse détaillée. Voir l'analyse d'adéquation ci-dessus.

Description

HORIZON Recognition Prize Call: HORIZON-JU-EDCTP3-2026-OUTSRESEARCHTEAMPRIZE Programme period: 2021 - 2027

Source officielle
Voir l'appel ↗